Dr. Thomas Nunns is the drug substance subject matter expert supporting the commercial team at Arcinova, A Quotient Sciences Company. 

Thomas joined the company in 2019 as a synthetic chemist, working on process development and manufacturing projects for a wide variety of customers, before transitioning into the commercial team. In his current role, he is responsible for the scoping and design of drug substance programs, their handover into the operational teams and supporting the projects throughout their delivery at Arcinova.

Thomas is a synthetic chemist by training and holds a Ph.D. from the University of Bristol Centre for Doctoral Training in Chemical Synthesis.